GlassScriptPhysician profile
Prabhat Uppuluri
NPI 1710322011
$1,595.15
in general payments reported to CMS, 2019-2025
19 companies · $66.97 in 2025
The $66.97 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $987 · 2020: $48.18 · 2021: $172 · 2022: $95.94 · 2024: $225 · 2025: $66.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $292.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $258.46 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $176.34 | 2019-2022 | |
| Astellas Pharma US INC | $154.24 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $123.89 | 2019 | |
| Axsome Therapeutics, INC. | $121.52 | 2024 | Auvelity |
| Cumberland Pharmaceuticals, INC. | $112.39 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.18 | 2019-2021 | |
| Pfizer INC. | $91.86 | 2019-2024 | |
| Abbvie INC. | $79.99 | 2024 | |
| Aimmune Therapeutics, INC. | $66.97 | 2025 | Vowst |
| Bayer Healthcare Pharmaceuticals INC. | $62.29 | 2019 | |
| Novartis Pharmaceuticals Corporation | $55.54 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.32 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $47.59 | 2019 | |
| Shionogi INC | $23.40 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $22.47 | 2019 | |
| Eusa Pharma (US) LLC | $19.16 | 2019 | |
| Csl Behring | $16.31 | 2019 | |
| Mylan Specialty L.P. | $14.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prabhat Uppuluri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.